Thank you very much ... I do truly appreciate all of the high quality, highly professional statistical services from the team at Cytel."
Jim Johnson, Senior Director, Biostatistics and Data Sciences, Flexion
The software collaboration with Cytel has added value to our decision-making approach. The creation of consistent, presentation quality decision plots eases communication between stakeholders. With this software tool in place decision information can now be generated in real-time. As well as saving time for the statisticians and the clinical project team, improving decision making will help us develop the right medicines, and get these medicines to patients faster.”
James Matcham, Head of Early Clinical Development Biometrics, AstraZeneca
We statisticians at UCB extend our sincere appreciation for your Cytel symposium on pressing topics in our daily operations and study success. The presentations were excellent and the internal & external audience engagement was invaluable”.
Michael Colopy, Statistician, UCB
The ADaM datasets for -008 are some of the finest I have ever seen constructed in my career. Very clean and very easy to work with - Thank you!”
Jim Johnson, Senior Director, Biostatistics and Data Sciences, Flexion
Thank you for all your work and perseverance over the last year as we’ve prepared for this analysis - your contributions were critical and we sincerely value your dedication and our partnership."
Lynne Navale, Vice President, Biometrics, Kite Pharma
It’s a pleasure to be working with such talented biostatisticians who are so creative and also so engaged and available to help us meet critical program milestones.”
Michael Vasconcelles, Chief Medical Officer, Unum Therapeutics Inc.
Cytel has provided excellent data management and literature data extraction support for many projects. The team has provided quality work, on time, and they have been responsive to changes in needs. With all of that, they have been a pleasure to work with too!”
Bill Denney, Chief Scientist, Human Predictions, LLC
I have worked with StatXact and LogXact for nearly 25 years, and access to the software has given me great reassurance when assessing and analyzing sparse and small sample size data. Cytel software is “state of the science”, and I have always been particularly impressed with how it has continually evolved to meet the needs of the research and clinical trials community.”
Joseph Cappelleri, Executive Director of Biostatistics, Pfizer Inc